Ensures that the Investigator and study team follow the approved protocol and all approved amendment(s), if any, and adhere to current regulations, applicable ICH/GCP guidelines, local policies and standard operating procedures, including Monitoring standards and guidelines. 

Ensures that the investigator and the investigator’s study team are performing the specified study functions, in accordance with any other written agreement between the sponsor and the investigator, and have not delegated these functions to unauthorized individuals. 

Adheres to the protocols’ Monitoring Plans; e.g. monitoring visit type, frequency, and required critical monitoring activities by utilizing monitoring tracking forms and other monitoring related tools and templates. 

Performs study conduct trainings to research teams such as Site Initiation Visits for Clinical Trials and Initial Site Trainings for Clinical Research  

Develops and updates Study conduct training materials as requested for researchers and study conduct templates as needed.  

Assists in the development and writing of clinical research monitoring plans. 

Conducts the monitoring visits, writes the monitoring report in details by summing up the findings of the monitoring process and put the corrective/prevention action plan for these findings. The CRM then reports to the next in line authority for approval. Issues the letter to the principal investigator and follows up with the PI to close the findings.  

Verifies that the investigator has filed the current Investigator’s Brochure, all documents, and all study supplies needed to conduct the study properly in their study investigator sites files and comply with the applicable regulatory requirements. 

Verifies that the investigator has adequate qualifications and resources documented in their study investigator sites files and remains adequate throughout the study period. 

Validates that the investigator and the investigator’s study team are adequately informed about the study through their training records. 

Verifies that the investigator is enrolling only eligible subjects and reports subject recruitment rate. 

Verifies that written informed consent was obtained from each subject before participation in the study. 

Verifies subjects are provided with necessary instruction on properly using, handling, storing, and returning the investigational product(s). 

Checks that data required by the protocol are reported accurately on the Case Report Forms (CRF)/study data collection sheets and are consistent with the source documents, verifies that study data entered on the CRFs is consistent with patient clinical notes and other source documentation (source data verification), and Informs the investigator of any CRF entry error, omission, or illegibility. Ensures as well that proper corrective plan is taken as per ICH-GCP standards.  

Verifies that all withdrawals and dropouts of enrolled subjects from the study are reported and explained on the CRFs. 

Checks whether all adverse events (AEs) and unanticipated problems (UP) are appropriately reported within the time periods required by GCP, the protocol, the IRB/IEC, the sponsor, and the applicable regulatory requirement(s). In case of any unreported AEs / Ups, the CRM has to report this on the monitoring report and ask the PI to report it to the IRB 

Verifies that the investigator provides all the required reports, notifications, applications, and submissions and that these documents are accurate, complete, timely, and legible, dated, and identify the study. 

Determines whether the investigator is maintaining the essential documents in their regulatory study binders.  

Meets expected timelines for completion of monitoring activities and submission of written monitoring reports.  

Track and report all issues identified through the monitoring visits on the monitoring tracking tools 

Communicates deviations from the protocol, SOPs, GCP, and the applicable regulatory requirements to the investigator and ensures appropriate action is designed to prevent recurrence of the detected deviations. Communicate to HRPP Director and IRB Office any critical or major deviation/violation that would require intervention from these offices promptly. 

يلتزم بمعايير سدرة كما وردت في مدونة قواعد السلوك وسياسات تضارب المصالح 

يلتزم بقيم سدرة ويعززها